A significant advance in cancer research is arising with the use of VHH fragments to re-engage mutated p53. This crucial malignant protector protein is frequently inactivated in several kinds of tumors, causing https://followbookmarks.com/story22068719/mini-antibodies-revive-the-p53-protein-the-new-hope-for-cancer-therapy